Expert Guidance on GLP-1 Receptor Agonists in Type 2 Diabetes: A Case-Based Approach

Download All
Learn the glycemic and extraglycemic properties of GLP-1 RA therapies to lower A1C, reduce comorbidity risks, and improve patient adherence and self-care in the management of T2D.
person default
Vanita R. Aroda, MD
person default
Arthi Thirumalai, MBBS

On-Demand Webcast

On-demand Webinar focusing on current best practices in leveraging GLP-1 RA therapy in T2D management.

person default Vanita R. Aroda, MD person default Arthi Thirumalai, MBBS Physicians: maximum of 1.0 AMA PRA Category 1 Credit ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) Registered Nurses: 1.0 Nursing contact hour Released: December 4, 2020 Expired: December 31, 2021
Provided by the Endocrine Society, in collaboration with Clinical Care Options.

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue